N
Natixis Portfolio holdings
AUM
$20.1B
1-Year Return
17.51%
Natixis is a global financial services business line of Groupe BPCE, offering a range of services including corporate and investment banking, asset management, insurance, and wealth management, with a focus on green and sustainable finance.
This Quarter Return
+15.58%
1 Year Return
+17.51%
3 Year Return
+106.1%
5 Year Return
+162.29%
10 Year Return
+380.38%
AUM
$18B
AUM Growth
+$4.78B
(+36%)
Cap. Flow
+$3.26B
Cap. Flow
% of AUM
18.15%
Top 10 Holdings %
Top 10 Hldgs %
39.42%
Holding
1,254
New
248
Increased
345
Reduced
296
Closed
273
Top Buys
| 1 |
Microsoft
MSFT
|
+$563M |
| 2 |
Apple
AAPL
|
+$463M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$442M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$315M |
| 5 |
NVIDIA
NVDA
|
+$262M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$663M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$104M |
| 3 |
Prologis
PLD
|
+$102M |
| 4 |
Cigna
CI
|
+$90.1M |
| 5 |
Procter & Gamble
PG
|
+$82.8M |
Sector Composition
| 1 | Technology | 38.81% |
| 2 | Consumer Discretionary | 10.31% |
| 3 | Financials | 9.02% |
| 4 | Healthcare | 7.94% |
| 5 | Communication Services | 4.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
751
Udemy
UDMY
$1.02B
| $98.6K | ﹤0.01% |
8,967
+3,391
| +61% | +$37.3K |
|
752
Axsome Therapeutics
AXSM
$6.45B
| $98.6K | ﹤0.01% |
1,235
+148
| +14% | +$11.8K |
|
753
Qfin Holdings, Inc. American Depositary Shares
QFIN
$3.72B
| $98.5K | ﹤0.01% |
5,347
-1,300
| -20% | -$24K |
|
754
Telephone and Data Systems
TDS
$4.41B
| $96.1K | ﹤0.01% |
+6,000
| New | +$96.1K |
|
755
Columbus McKinnon
CMCO
$428M
| $95.7K | ﹤0.01% |
2,145
-19
| -0.9% | -$848 |
|
756
Paycom
PAYC
$12.6B
| $95.5K | ﹤0.01% |
+480
| New | +$95.5K |
|
757
Pacira BioSciences
PCRX
$1.2B
| $95K | ﹤0.01% |
+3,250
| New | +$95K |
|
758
PIMCO Dynamic Income Fund
PDI
$7.6B
| $94.6K | ﹤0.01% |
4,902
-806
| -14% | -$15.5K |
|
759
Ameren
AEE
$27B
| $91.4K | ﹤0.01% |
+1,236
| New | +$91.4K |
|
760
C.H. Robinson
CHRW
$14.9B
| $90.2K | ﹤0.01% |
1,185
-12,454
| -91% | -$948K |
|
761
Robert Half
RHI
$3.66B
| $90.2K | ﹤0.01% |
+1,138
| New | +$90.2K |
|
762
West Fraser Timber
WFG
$6.01B
| $90.1K | ﹤0.01% |
1,043
-9
| -0.9% | -$777 |
|
763
Columbia Sportswear
COLM
$3.1B
| $89.3K | ﹤0.01% |
1,100
-13,200
| -92% | -$1.07M |
|
764
Ionis Pharmaceuticals
IONS
$10.3B
| $85K | ﹤0.01% |
1,961
-917
| -32% | -$39.8K |
|
|
LICY
765
DELISTED
Li-Cycle Holdings Corp.
LICY
| $83.5K | ﹤0.01% |
10,130
-386
| -4% | -$3.18K |
|
766
Hamilton Lane
HLNE
$6.52B
| $83.4K | ﹤0.01% |
740
-274
| -27% | -$30.9K |
|
767
N-able
NABL
$1.56B
| $80.8K | ﹤0.01% |
6,184
-6,372
| -51% | -$83.3K |
|
768
Kymera Therapeutics
KYMR
$3.11B
| $79.6K | ﹤0.01% |
1,979
-1,992
| -50% | -$80.1K |
|
769
CNX Resources
CNX
$4.1B
| $78.8K | ﹤0.01% |
+3,324
| New | +$78.8K |
|
770
Legend Biotech
LEGN
$6.39B
| $78.8K | ﹤0.01% |
1,404
-618
| -31% | -$34.7K |
|
771
Apellis Pharmaceuticals
APLS
$3.4B
| $78.7K | ﹤0.01% |
1,339
-90,719
| -99% | -$5.33M |
|
772
SS&C Technologies
SSNC
$21.7B
| $77.2K | ﹤0.01% |
+1,200
| New | +$77.2K |
|
773
Sarepta Therapeutics
SRPT
$1.85B
| $77K | ﹤0.01% |
+595
| New | +$77K |
|
|
HEES
774
DELISTED
H&E Equipment Services
HEES
| $76.4K | ﹤0.01% |
1,190
-11
| -0.9% | -$706 |
|
775
BioNTech
BNTX
$24.5B
| $73.2K | ﹤0.01% |
793
-422
| -35% | -$38.9K |
|